138 related articles for article (PubMed ID: 308425)
21. Lymphocyte transformation in lepromatous leprosy: a study of the influence of disease activity and symptom duration.
Brown AE; Vithayasai V; Scollard DM; Nelson KE; Moses V; Schauf V; Makonkawkeyoon S
Southeast Asian J Trop Med Public Health; 1986 Mar; 17(1):104-10. PubMed ID: 3738597
[TBL] [Abstract][Full Text] [Related]
22. Type 1 reactions in leprosy--heterogeneity in T-cell functions related to the background leprosy type.
Laal S; Mishra RS; Nath I
Int J Lepr Other Mycobact Dis; 1987 Sep; 55(3):481-93. PubMed ID: 2958570
[TBL] [Abstract][Full Text] [Related]
23. Dependence of proliferative activity of lymphocytes on basal levels of lymphocytic cyclic nucleotides in lepromatous leprosy patients.
Balybin ES; Naumov VZ
Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):52-6. PubMed ID: 3011927
[TBL] [Abstract][Full Text] [Related]
24. M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy.
Shankar P; Agis F; Wallach D; Flageul B; Cottenot F; Augier J; Bach MA
J Immunol; 1986 Jun; 136(11):4255-63. PubMed ID: 2422278
[TBL] [Abstract][Full Text] [Related]
25. Evidence for the presence of M. leprae reactive T lymphocytes in patients with lepromatous leprosy.
Nath I; Sathish M; Jayaraman T; Bhutani LK; Sharma AK
Clin Exp Immunol; 1984 Dec; 58(3):522-30. PubMed ID: 6391762
[TBL] [Abstract][Full Text] [Related]
26. T-cell responses of leprosy patients and healthy contacts toward separated protein antigens of Mycobacterium leprae.
Gulle H; Schoel B; Chiplunkar S; Gangal S; Deo MG; Kaufmann SH
Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):44-53. PubMed ID: 1602193
[TBL] [Abstract][Full Text] [Related]
27. Comparison of various preparations of Mycobacterium leprae and other mycobacteria by lymphocyte stimulation.
Bjune G
Int J Lepr Other Mycobact Dis; 1978; 46(3-4):386-93. PubMed ID: 83309
[TBL] [Abstract][Full Text] [Related]
28. Analysis of T-cell and B-cell responses to recombinant M. leprae antigens in leprosy patients and in healthy contacts: significant T-cell responses to antigens in M. leprae nonresponders.
Thole JE; Janson AA; Kifle A; Howe RC; McLean K; Nurilygn A; Filley E; Shannon EJ; Bulla GJ; Hermans J
Int J Lepr Other Mycobact Dis; 1995 Sep; 63(3):369-80. PubMed ID: 7594920
[TBL] [Abstract][Full Text] [Related]
29. T and B lymphocytes and blastogenesis in leprosy.
Sharma S; Ganguly NK; Kumar B; Kaur S; Chakravarty RN
Lepr India; 1979 Apr; 51(2):194-202. PubMed ID: 314551
[TBL] [Abstract][Full Text] [Related]
30. [The effect of human cord plasma on the incorporation of 3H-thymidine by PHA-stimulated peripheral blood lymphocytes of cervical cancer patient (author's transl)].
Fujii S; Nakashima N; Kobayashi H; Mori T; Nishimura T
Acta Obstet Gynaecol Jpn; 1980 Dec; 32(12):1945-50. PubMed ID: 7211212
[TBL] [Abstract][Full Text] [Related]
31. In vitro effect of interleukin-2 on proliferative responses of peripheral blood T cells from leprosy patients.
Choi IH; Shin JS; Kim JD; Kim SJ
Yonsei Med J; 1991 Sep; 32(3):237-42. PubMed ID: 1781183
[TBL] [Abstract][Full Text] [Related]
32. IgA, IgM and IgG anti-M. leprae antibodies in babies of leprosy mothers during the first 2 years of life.
Melsom R; Harboe M; Duncan ME
Clin Exp Immunol; 1982 Sep; 49(3):532-42. PubMed ID: 6756719
[TBL] [Abstract][Full Text] [Related]
33. Immunological status of maculo-anaesthetic leprosy: T and B lymphocytes and serum immunoglobulins.
Rao SS; Rao TD; Rao PR
Lepr India; 1982 Jul; 54(3):471-8. PubMed ID: 6983629
[TBL] [Abstract][Full Text] [Related]
34. Cellular immune responses to mycobacterial heat shock proteins in Nepali leprosy patients and controls.
Roche PW; Theuvenet WJ; Britton WJ
Int J Lepr Other Mycobact Dis; 1992 Mar; 60(1):36-43. PubMed ID: 1602192
[TBL] [Abstract][Full Text] [Related]
35. In vitro studies on dermal granulomas of human leprosy: characterization of cells using monoclonal antibodies.
Narayanan RB; Girdhar BK; Lavania RK; Sengupta U
Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):268-72. PubMed ID: 3088184
[TBL] [Abstract][Full Text] [Related]
36. Immunologic responses in patients with lepromatous leprosy.
Rea TH; Quismorio FP; Harding B; Nies KM; Di Saia PJ; Levan NE; Friou GJ
Arch Dermatol; 1976 Jun; 112(6):791-800. PubMed ID: 1085131
[TBL] [Abstract][Full Text] [Related]
37. Lymphocyte blastogenesis and lepromin reactivity in leprosy patients and their parents.
Foss NT; Pagnano PM; Bechelli LM; Simoes AL
Acta Leprol; 1990; 7(2):119-28. PubMed ID: 2220296
[TBL] [Abstract][Full Text] [Related]
38. Immunologic defects in leprosy patients. I. Evidence of immune aberration of suppressor-T lymphocytes in lepromatous leprosy.
Makonkawkeyoon S; Kasinrerk W; Dettrairat S; Vithayasai V
Int J Lepr Other Mycobact Dis; 1990 Jun; 58(2):302-10. PubMed ID: 2142947
[TBL] [Abstract][Full Text] [Related]
39. Suppress of the increase in free cytosolic calcium during the inhibition of T-cell activation by an autoantibody present in the serum of leprosy patients.
Poulton TA; Gallagher A; Beck JS
Immunology; 1989 Nov; 68(3):353-8. PubMed ID: 2592010
[TBL] [Abstract][Full Text] [Related]
40. Blastogenic response with autologous plasma and Mitsuda's reaction in leprosy patients and their unaffected sibs.
Foss NT; Pagnano PM; Bechelli LM; Lima Filho EC
Acta Leprol; 1991; 7(4):335-45. PubMed ID: 1950443
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
